Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-20.0%
0%
-20.0%
6 Months
-20.0%
0%
-20.0%
1 Year
-20.0%
0%
-20.0%
2 Years
-50.0%
0%
-50.0%
3 Years
-50.0%
0%
-50.0%
4 Years
-66.67%
0%
-66.67%
5 Years
-66.67%
0%
-66.67%
Crushmetric Group Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-8.17%
EBIT Growth (5y)
-181.12%
EBIT to Interest (avg)
-2.58
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.11
Sales to Capital Employed (avg)
0.38
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-6.59
EV to EBIT
-9.81
EV to EBITDA
-9.81
EV to Capital Employed
-7.49
EV to Sales
26.87
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
Bullish
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'18
Dec'18
Dec'17
Change(%)
Net Sales
1.00
1.20
-16.67%
Operating Profit (PBDIT) excl Other Income
-3.40
-1.50
-126.67%
Interest
0.00
0.00
Exceptional Items
-0.00
-0.00
Consolidate Net Profit
-3.60
-1.70
-111.76%
Operating Profit Margin (Excl OI)
-3,458.20%
-1,404.60%
-205.36%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2018 is -16.67% vs 20.00% in Dec 2017
Consolidated Net Profit
YoY Growth in year ended Dec 2018 is -111.76% vs -54.55% in Dec 2017
About Crushmetric Group Ltd. 
Crushmetric Group Ltd.
Pharmaceuticals & Biotechnology
MiLOC Group Limited is a United Kingdom-based holding company of a group engaged in the provision of traditional Chinese medicine (TCM) healthcare services, including consultations and TCM therapies, through a network of clinics in Hong Kong, and the sale and distribution of TCM healthcare and skincare products through wholesale outlets and TCM clinics, its retail store in Hong Kong and other non-related TCM retail stores, as well as directly to customers through its online store. It operates through two business segments: Sales of TCM and healthcare and skincare products, and Provision of TCM healthcare services. Its Rorrico is a TCM product for the treatment of influenza viruses, including the Influenza A virus and its sub-type virus, pandemic H1N1 or Swine flu. Rorrico's formula contains approximately 20 herbs. It is confected with honeysuckle, radix isatidis, rhubarb, codonopsis pilosula, amomum villosum, malt and white atractylodes medicine.
Company Coordinates 
Company Details
Unit 02, 21/F, Bayfield Building,, 99 Hennessy Road, Wanchai NA None : None
Registrar Details






